Background: Adverse drug reactions (ADRs) continue to be a leading source of morbidity, hospitalization, hospital stay, and avoidable health expenditure. The conventional pharmacovigilance process has relied heavily upon spontaneous, manual reporting, prone to the following limitations: under-reporting, delayed reporti...